Bristol-Myers sues immu**therapy exec who left for AstraZeneca
NEW YORK (Reuters) - Bristol-Myers Squibb has sued a top cancer immu**therapy executive for violating confidentiality and **n-compete agreements after he left for direct competitor AstraZeneca, court documents show.